BC
Brinker Capital’s Supernus Pharmaceuticals SUPN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-17,727
| Closed | -$587K | – | 976 |
|
|
2019
Q2 | $587K | Sell |
17,727
-1,186
| -6% | -$39.3K | 0.02% | 647 |
|
|
2019
Q1 | $663K | Buy |
18,913
+1,511
| +9% | +$53K | 0.03% | 593 |
|
|
2018
Q4 | $578K | Buy |
17,402
+1,379
| +9% | +$45.8K | 0.03% | 560 |
|
|
2018
Q3 | $807K | Buy |
16,023
+1,166
| +8% | +$58.7K | 0.03% | 558 |
|
|
2018
Q2 | $889K | Buy |
14,857
+926
| +7% | +$55.4K | 0.03% | 520 |
|
|
2018
Q1 | $638K | Buy |
13,931
+640
| +5% | +$29.3K | 0.03% | 629 |
|
|
2017
Q4 | $530K | Sell |
13,291
-584
| -4% | -$23.3K | 0.02% | 670 |
|
|
2017
Q3 | $555K | Buy |
13,875
+1,651
| +14% | +$66K | 0.02% | 639 |
|
|
2017
Q2 | $527K | Buy |
12,224
+532
| +5% | +$22.9K | 0.02% | 515 |
|
|
2017
Q1 | $366K | Buy |
11,692
+420
| +4% | +$13.1K | 0.02% | 714 |
|
|
2016
Q4 | $285K | Buy |
+11,272
| New | +$285K | 0.02% | 594 |
|